ADVERTISEMENT

Manulife Frees Up $1.6 Billion in Capital With Annuity Deal

Manulife Frees Up $1.6 Billion in Capital With U.S. Annuity Deal

Manulife Financial Corp. is freeing up C$2 billion ($1.6 billion) of capital, much of which it plans to devote to stock buybacks, as part of a deal to reinsure the majority its U.S. variable-annuity business.

Venerable Holdings Inc. will reinsure more than 75% of the legacy U.S. variable-annuity block, consisting primarily of policies with guaranteed minimum withdrawal benefits, Toronto-based Manulife said Monday in a statement. Manulife said it plans to deploy “a significant portion” of the capital to buy back shares, without providing a precise figure.

Manulife is reducing its exposure to the variable annuities as it focuses on higher-growth businesses like its wealth- and asset-management operations and the Asian division. Analysts have said such a deal could help the insurer’s shares, which have underperformed those of peers this year.

“This transaction represents a significant milestone for Manulife,” Chief Executive Officer Roy Gori said in the statement. “The agreement to reinsure a substantial portion of our U.S. VA block reduces risk, releases approximately C$2 billion of capital and unlocks shareholder value.”

Manulife said it will increase the size of its previously announced share-buyback program to 5% of shares outstanding, up from the 2% targeted earlier. The remainder of the capital from the reinsurance transaction will be used to increase the company’s excess capital position.

Manulife Frees Up $1.6 Billion in Capital With Annuity Deal

The deal, expected to close in the first quarter of next year, will cut annual earnings by about C$200 million in 2022, with the effect decreasing over time, Manulife said. The transaction immediately adds to the insurer’s book value, and Manulife said it remains committed to its medium-term financial targets, including growth in core earnings per share of 10% to 12%.

“This variable-annuity transaction is a positive catalyst for the stock,” Scott Chan, an analyst at Canaccord Genuity Group Inc., said in a note Monday. The “deal should help re-rate shares of Manulife.”

Manulife shares rose 2.4% to C$25.47 at 10:20 a.m. in Toronto, topping the 0.2% gain for the broader S&P/TSX Composite Index. The stock has gained 12% this year, trailing the 26% gain for rival Sun Life Financial Inc. and the 27% advance for Great-West Lifeco Inc.

While the transaction does reduce Manulife’s risks, figures that the company released along with the deal details revealed that long-term-care and remaining variable-annuity blocks in Canada and Japan generate about 20% of its earnings, said Gabriel Dechaine, an analyst at National Bank of Canada.

“Clarity on Manulife’s earnings mix may dampen enthusiasm related to de-risking the business,” Dechaine said in a note Tuesday.

©2021 Bloomberg L.P.